Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.
about
Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery PerspectivesIn Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer DrugInferring Growth Control Mechanisms in Growing Multi-cellular Spheroids of NSCLC Cells from Spatial-Temporal Image DataInsights on Structural Characteristics and Ligand Binding Mechanisms of CDK2Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients.Cis-Nerolidol Induces Endoplasmic Reticulum Stress and Cell Death in Human Hepatocellular Carcinoma Cells through Extensive CYP2C19 and CYP1A2 Oxidation.Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV.Scaffold Hopping Approach to a New Series of Pyridine Derivatives as Potent Inhibitors of CDK2.CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.Screening of the 'Stasis Box' identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus.Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives.Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.Impact of common cytostatic drugs on pollen fertility in higher plants.Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases.Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.Classification of in vitro genotoxicants using a novel multiplexed biomarker assay compared to the flow cytometric micronucleus test.CDK9 inhibitors in acute myeloid leukemia.Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex.Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors
P2860
Q26771369-ED0EE97F-F29F-4111-9D51-F4294ED542A5Q28546330-13F125BD-DEB3-493E-8B74-8980ED8947A9Q31044284-55F6E8E9-9CF8-416F-9333-AD41D25F7254Q35722786-AE3B2522-89AF-4436-A8D1-9E10A71BAA4FQ38544813-F6D75AC7-6785-44D0-8245-F1BCBD4CD691Q38703243-E278884F-A4CB-403A-AB8A-0154B8473111Q38714046-8EC9604B-E70A-493A-813D-8D9ABCA1ADD4Q38743546-069848A3-9A5D-4242-B0C5-C7AE834CA118Q38757713-9AFDCE37-0459-48B2-BA4D-1F3FCBCF71BFQ38794658-C67EADE6-B7BB-48B4-BA08-54F18201A804Q38828117-F71B9B32-54D6-4298-8889-D51DC9992B83Q39366636-858A46CC-7FC1-4377-B879-5CBE62E0000FQ40146751-B7085920-3728-4F64-9347-952FC5084FEBQ42736773-D25372C8-2496-4E0E-A6CF-16C9ADF30F38Q46420204-A792081A-38FE-407D-9431-529DB6810C67Q46758556-30A474C3-C2C3-46CD-B081-DF5CE82DDA74Q47161171-77A0C911-5D2F-4748-9AAD-18C58F87D45CQ47611731-68982C8E-5DCB-4176-9752-3B3C14447B44Q47756444-164D7D51-C62B-47E2-B8E5-3C4E223BFC93Q50318294-B7160C4B-83F6-48E2-A749-5A74948F5D90Q54979952-8E203A50-00E2-4CAC-8503-2D4647F7C35EQ58697467-F5BF3613-D572-4058-AA15-0DAC8CFB6CA4
P2860
Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cyclin-dependent kinase inhibi ...... re are we now? A short survey.
@en
type
label
Cyclin-dependent kinase inhibi ...... re are we now? A short survey.
@en
prefLabel
Cyclin-dependent kinase inhibi ...... re are we now? A short survey.
@en
P2860
P1433
P1476
Cyclin-dependent kinase inhibi ...... ere are we now? A short survey
@en
P2093
Gaëlle Mariaule
P2860
P304
14366-14382
P356
10.3390/MOLECULES190914366
P407
P577
2014-09-11T00:00:00Z